484: Milestones for a CFO Barn Raiser | Andrew Guggenhime, CFO, Dermira
When asked about his arrival at Dermira, CFO Andrew Guggenhime explains: "I was the 22nd employee, and today we have over 300."
Along the way, the company executed an IPO, reached a market value of $1 billion, received FDA approval for its first medication (last June), and brought the offering to market (last October). Not bad for a five-year CFO sprint into the land of leading-edge medical dermatology.
Looking back, Guggenhime says: "When I joined Dermira, we had one other person on the finance team. We had no employees on our legal team. We had no employees on our IT team. And those were…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.